Wacker: Wacker Biotech expands mRNA biopharma development through collaboration with RNAV8
Wacker Biotech announced a strategic collaboration with RNAV8 Bio, a pioneer in mRNA engineering for the development of therapies for biopharma The post Wacker Biotech expands mRNA biopharma development through collaboration with RNAV8 appeared first on Chemical Engineering.
Read full article »
WACKER is a Germany-based chemical company that manufactures and supplies products such as amino acids and polymer resins for sectors including cosmetics and aerospace.
Read more